Terminology Service for NFDI4Health
All terms in CLO
| Label | Id | Description |
|---|---|---|
| IGF006/95 cell | CLO_0004505 | |
| IGF006/98 cell | CLO_0004508 | |
| IGF006/99 cell | CLO_0004509 | |
| pseudostratified ciliated columnar epithelium | UBERON_0010499 | |
| ciliated columnar epithelium | UBERON_0007592 | |
| pseudostratified columnar epithelium | UBERON_0010498 | |
| carbohydrate derivative | CHEBI_63299 | |
| salivary gland cancer | DOID_8850 | |
| salivary gland disease | DOID_10854 | |
| acute monocytic leukemia | DOID_8864 | [OMIM mapping confirmed by DO. [SN].] |
| myeloid leukemia | DOID_8692 | |
| breast carcinoma | EFO_0000305 | [A carcinoma that originates from breast tissue., A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.] |
| Burkitt's lymphoma | EFO_0000309 | [A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.] |
| lymphosarcoma and reticulosarcoma | DOID_8716 | |
| myopathy | EFO_0002970 | |
| limb-girdle muscular dystrophy | EFO_0000310 | [A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms (called LGMDs) involving genes encoding muscle membrane proteins such as the sarcoglycan (SARCOGLYCANS) complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS (the pelvic and shoulder girdles).] |
| oxidising agent | CHEBI_63248 | |
| chemical role | CHEBI_51086 | |
| CCAAT/enhancer-binding protein alpha | PR_000005307 | [Category=gene. Requested by=CL.] |
| carboxylic acid biosynthetic process | GO_0046394 |